AAAAAA

   
Results: 1-22 |
Results: 22
Helicobacter pylori infection affects eosinophilic cationic protein in thegastric juice of patients with idiopathic chronic urticaria
Authors: Ojetti, V Armuzzi, A De Luca, A Nucera, E Franceschi, F Candelli, M Zannoni, GF Danese, S Di Caro, S Vastola, M Schiavino, D Gasbarrini, G Patriarca, G Pola, P Gasbarrini, A
Citation: V. Ojetti et al., Helicobacter pylori infection affects eosinophilic cationic protein in thegastric juice of patients with idiopathic chronic urticaria, INT A AL IM, 125(1), 2001, pp. 66-72
IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival
Authors: Katsaros, D Yu, H Levesque, MA Danese, S Genta, F Richiardi, G Fracchioli, S Khosravi, MJ Diamandi, A Gordini, G Diamandis, EP Massobrio, M
Citation: D. Katsaros et al., IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival, EUR J CANC, 37(4), 2001, pp. 478-485
Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study
Authors: Gasbarrini, A Anti, M Franceschi, F Armuzzi, A Cotichini, R Ojetti, V Candelli, M Lippi, ME Paolucci, M Cicconi, V Cammarota, G Danese, S Silveri, NG Catananti, C Pola, P Stroffolini, T Gasbarrini, G
Citation: A. Gasbarrini et al., Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study, EUR J GASTR, 13(2), 2001, pp. 185-189
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretrested metastatic breast cancer patients. A multicenter phase II trial
Authors: Donadio, M Manzin, E Berruti, A Bottini, A Gorzegno, G Danese, S DeFabiani, E Sarobba, MG Lorusso, V Castiglione, F Moro, G Bertetto, O Bumma, C Dogliotti, L
Citation: M. Donadio et al., Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretrested metastatic breast cancer patients. A multicenter phase II trial, CANC CHEMOT, 47(5), 2001, pp. 391-396
Helicobacter pylori infection in rheumatoid arthritis - Reply
Authors: Danese, S Gasbarrini, A
Citation: S. Danese et A. Gasbarrini, Helicobacter pylori infection in rheumatoid arthritis - Reply, J RHEUMATOL, 28(5), 2001, pp. 1196-1196
Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels
Authors: Danese, S Papa, A Gasbarrini, G Gasbarrini, A
Citation: S. Danese et al., Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels, J RHEUMATOL, 28(12), 2001, pp. 2764-2765
Is cytotoxic-associated gene A-positive Helicobacter pylori important?
Authors: Danese, S Candelli, M Papa, A Gasbarrini, A
Citation: S. Danese et al., Is cytotoxic-associated gene A-positive Helicobacter pylori important?, J CLIN GAST, 32(1), 2001, pp. 91-92
Efficacy and tolerability of antibiotics in patients undergoing H-pylori eradication
Authors: Danese, S Armuzzi, A Romano, A Cremonini, F Candelli, M Franceschi, F Ojetti, V Venuti, A Pola, P Gasbarrini, G Gasbarrini, A
Citation: S. Danese et al., Efficacy and tolerability of antibiotics in patients undergoing H-pylori eradication, HEP-GASTRO, 48(38), 2001, pp. 465-467
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa
Authors: Danese, S Cremonini, F Armuzzi, A Candelli, M Papa, A Ojetti, V Pastorelli, A Di Caro, S Zannoni, G De Sole, P Gasbarrini, G Gasbarrini, A
Citation: S. Danese et al., Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa, SC J GASTR, 36(3), 2001, pp. 247-250
When can unfractionated heparin really be useful in the treatment of ulcerative colitis?
Authors: Papa, A Danese, S Gasbarrini, G Gasbarrini, A
Citation: A. Papa et al., When can unfractionated heparin really be useful in the treatment of ulcerative colitis?, GASTROENTY, 120(5), 2001, pp. 1306-1307
Severe liver injury associated with zafirlukast
Authors: Danese, S De Vitis, I Gasbarrini, A
Citation: S. Danese et al., Severe liver injury associated with zafirlukast, ANN INT MED, 135(10), 2001, pp. 930-930
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease
Authors: Papa, A De Stefano, V Danese, S Chiusolo, P Persichilli, S Casorelli, I Zappacosta, B Giardina, B Gasbarrini, A Leone, G Gasbarrini, G
Citation: A. Papa et al., Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease, AM J GASTRO, 96(9), 2001, pp. 2677-2682
Thrombotic complications in inflammatory bowel disease: A multifactorial etiology
Authors: Papa, A De Stefano, V Danese, S Gasbarrini, A Gasbarrini, G
Citation: A. Papa et al., Thrombotic complications in inflammatory bowel disease: A multifactorial etiology, AM J GASTRO, 96(4), 2001, pp. 1301-1302
Helicobacter pylori infection and migraine - Possible role in aetiology and therapeutic implications
Authors: Gasbarrini, A Franceschi, F Gabrielli, M Fiore, G Candelli, M Zocco, MA Danese, S Carloni, E Santoliquido, A Gerardino, L Pola, R Pola, P Giacovazzo, M Gasbarrini, G
Citation: A. Gasbarrini et al., Helicobacter pylori infection and migraine - Possible role in aetiology and therapeutic implications, CNS DRUGS, 13(2), 2000, pp. 97-101
Gender, chronic infection and myocardial infarction
Authors: Cremonini, F Danese, S Gasbarrini, A
Citation: F. Cremonini et al., Gender, chronic infection and myocardial infarction, J INTERN M, 247(1), 2000, pp. 156-156
Elevated homocysteine levels in patients with Raynaud's syndrome
Authors: Danese, S Candelli, M Gasbarrini, A
Citation: S. Danese et al., Elevated homocysteine levels in patients with Raynaud's syndrome, J RHEUMATOL, 27(8), 2000, pp. 2051-2051
High prevalence of Helicobacter pylori type I virulent strains in patientswith systemic sclerosis
Authors: Danese, S Zoli, A Cremonini, F Gasbarrini, A
Citation: S. Danese et al., High prevalence of Helicobacter pylori type I virulent strains in patientswith systemic sclerosis, J RHEUMATOL, 27(6), 2000, pp. 1568-1569
Sentinel lymph node and breast cancer staging: Final results of the Turin multicenter study
Authors: Casalegno, PS Sandrucci, S Bello, M Durando, A Danese, S Silvestro, L Pellerito, R Testori, O Roagna, R Giai, M Giani, R Bussone, R Favero, A Bisi, G Massobrio, M Giardina, G Mussa, GC Sismondi, P Mussa, A
Citation: Ps. Casalegno et al., Sentinel lymph node and breast cancer staging: Final results of the Turin multicenter study, TUMORI, 86(4), 2000, pp. 300-303
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease
Authors: Papa, A Danese, S Gasbarrini, A Gasbarrini, G
Citation: A. Papa et al., Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease, ALIM PHARM, 14(11), 2000, pp. 1403-1409
Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3cm and T4 breast cancer patients
Authors: Bellino, R Cortese, P Danese, S De Sanctis, C Durando, A Genta, F Grio, R Giardina, G Katsaros, D Massobrio, M Richiardi, G Vicelli, R
Citation: R. Bellino et al., Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3cm and T4 breast cancer patients, ANTICANC R, 20(6C), 2000, pp. 4825-4828
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
Authors: Arts, HJG Katsaros, D de Vries, EGE Massobrio, M Genta, F Danese, S Arisio, R Scheper, RJ Kool, M Scheffer, GL Willemse, PHB van der Zee, AGJ Suurmeijer, AJH
Citation: Hjg. Arts et al., Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma, CLIN CANC R, 5(10), 1999, pp. 2798-2805
A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin
Authors: Conte, P Ricci, S Antonuzzo, A Allegrini, G Palazzo, S Liguori, V Mastroianni, C Manzione, L Bilancia, D Dinota, A Di Costanzo, F Gasperoni, S Sdrobolini, A Montinari, F Mastore, M Casartelli, C Danese, S Richiardi, G Sismondi, P Locatelli, MC D'Antona, A Luporini, G Ambrosini, G Giustini, L Bascioni, R Acito, L Recchia, F De Filippis, S Rosselli, M Vinante, O Rossetti, F Azzarello, G Lucenti, A Galligioni, E Brugnara, S Rossi, A al Vesuvio, SS Bumma, C Donadio, M Cattaneo, MT Aapro, MS Libretti, A Nole, F Bizzarri, M Facco, R Buzzi, F Brugia, M Colucci, G Giotta, F Manente, P Vicario, G Martoni, A Angelelli, B Pusceddu, G Salaris, G Comella, G Gravina, A Morrica, B Rampello, G Colosini, G Migliosi, G Temperilli, L Monno, D Amadori, D Maltoni, M Ammuni, G Villanucci, A Cocconi, G Bella, M Farris, A Sanna, G Gebbia, V Testa, A Iacono, G LoPresti, G Pergola, M Gridelli, C Adamo, V Altavilla, G Barbieri, P Pisoni, G
Citation: P. Conte et al., A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin, ANTI-CANC D, 10(5), 1999, pp. 465-470
Risultati: 1-22 |